Originally written by: Yi Wei Pu Run, 1 week ago
At the beginning of 2018, Huzhou Puripharm Co., Ltd. and Huzhou Center of Industrial Biotechnology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (CAS), signed the cooperation agreement on seeking common development by jointly establishing the Puri Joint Research and Development Laboratory.
Puripharm Co., Ltd. is a company specializing in the development, production and application of functional bioactive ingredients and preparations. Currently the company has developed a series of bioactive ingredients by chemical synthesis, plant extraction and biotechnology, as well as new pharmaceutical and bioactive ingredients preparations based on nano-delivery system, etc.
The Huzhou Center of Industrial Biotechnology, Shanghai Institutes for Biological Sciences, CAS, was formally established in October, 2006, which is a technological platform that integrates industrialization research and development (R&D) with technological transfer, jointly built by the Huzhou Municipal People’s Government and Shanghai Institutes for Biological Sciences, CAS. Since its establishment, there has been more than 20 industrialization projects, and the cooperative enterprises have realized the project output value of more than 800 million yuan. Based in Huzhou, neighboring Shanghai and expanding to the Yangtze River Delta, the center owns an excellent technical R&D team in genetic engineering, enzyme engineering, separation and purification, pilot research and analysis, mainly focusing on industrial biotechnology (R&D, transformation on achievements and industrialized implementation) according to the characteristics of regional industries with the aim of promoting the structural adjustment and industrialization level of bio-industry in Huzhou and surrounding areas thereby boosting local and regional economic development.
In-depth R&D cooperation will be carried out on biomedical products that are of mutual concerns based on the complementary technological advantages of the two sides, with the expectations to achieve industrialization within three years.
About Puripharm
Puripharm Co., Ltd. is a high-tech medical and health company founded by senior biomedical experts and investors at home and abroad. Adhering to the concept of Quality by Design (QbD) and the golden standard of development with safety, efficiency and stability, Puripharm has developed a series of Bioactive Ingredients by combining modern biotechnological technologies, oriental traditional medicine wisdom and new preparation technologies such as nano-transfer. Puripharm also provides customers in health care industry with bioactive raw materials such as nano-coated dihydro oat avenanthramides (anti-inflammatory, anti-allergic), Hexamine dihydroxyethyl sulfonate (anti-acne, anti-dandruff, firming and anti-wrinkle), nano-coated retinal (vitamin A) , nano-coated resveratrol (whitening, anti-aging), nano-coated astaxanthin (anti-aging, anti-wrinkle), nano-coated multivitamins (anti-eye bags, anti-dark circles), quaternary ammonium salt-73 (anti-acne, anti-freckle), nano-coated lipoic acid (whitening, anti-acnemarks, anti-scars), nano-coated 377 (whitening), nano-coated curcumin (anti-inflammatory, anti-allergic), nano-coated salicylic acid (anti-acne, exfoliator), nano-coated Ceramide (moisturizing, repairing), nano-coated vitamin C (whitening, anti-oxidation), chlorogenic acid (anti-inflammatory, anti-allergic), betulin (repair, anti-allergic ), water-soluble natural yeast glucan (immunomodulation, repair), quaternized hydrolyzed keratin (hair care), quaternized hydrolyzed wheat protein (hair care), bio-gum (moisturizing), SOD (anti-inflammatory, anti-free radicals, whitening, and white blood cell extracts (immunomodulation, repair) . Others include functional bioactive substances needed in functional skin care products, functional foods and medical devices, and customized services for formulation development.
The article has been revised in 2018-07-13